STOCK TITAN

Vor to Participate in Two Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Vor Biopharma (Nasdaq: VOR) announced participation in two virtual investor conferences. The first is the H.C. Wainwright BioConnect 2022, with a pre-recorded presentation available on January 10, 2022, starting at 7:00 AM ET. The second event is the 2022 B Riley Virtual Oncology Conference, featuring a live webcast fireside chat on January 27, 2022, at 10:30 AM ET. Both presentations will be accessible through the company’s website, along with archived replays.

Vor Biopharma focuses on engineering hematopoietic stem cells to improve blood cancer treatments.

Positive
  • None.
Negative
  • None.

CAMBRIDGE, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Vor Biopharma (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that members of its senior management team will be participating in two upcoming virtual investor conferences:

H.C. Wainwright BioConnect 2022 Virtual Conference
Presentation Date: Monday, January 10, 2022
Time: Pre-recorded on-demand presentation available beginning at 7:00 AM ET

2022 B Riley Virtual Oncology Conference
Fireside Chat Live Webcast Date: Thursday, January 27, 2022
Time: 10:30 AM ET

The live and on demand webcasts of both presentations will be available on the Company's website at www.vobrbio.com. An archived replay of each webcast will also be available.

About Vor Biopharma
Vor Biopharma is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.

Contacts:

Investors:
Chris Brinzey
ICR Westwicke
+1 339-970-2843
chris.brinzey@westwicke.com

Media:
Sarah Spencer
Vice President, Corporate Communications, Vor
+1 857-242-6076
sspencer@vorbio.com


FAQ

When is Vor Biopharma's presentation at the H.C. Wainwright BioConnect 2022 Conference?

Vor Biopharma's presentation at the H.C. Wainwright BioConnect 2022 Conference is scheduled for January 10, 2022, with on-demand availability starting at 7:00 AM ET.

What time does Vor Biopharma's fireside chat at the B Riley Virtual Oncology Conference start?

The fireside chat for Vor Biopharma at the B Riley Virtual Oncology Conference is set for January 27, 2022, at 10:30 AM ET.

Where can I watch Vor Biopharma's presentations from the investor conferences?

You can watch Vor Biopharma's presentations from the investor conferences on their official website, where both live and archived replays will be available.

What is the focus of Vor Biopharma?

Vor Biopharma is focused on engineering hematopoietic stem cells to enhance targeted therapies for blood cancer patients post-transplant.

Vor Biopharma Inc.

NASDAQ:VOR

VOR Rankings

VOR Latest News

VOR Stock Data

59.34M
68.67M
1.17%
81.25%
2.49%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
CAMBRIDGE